Can Mumps Cause Sterility in Males? A Look at the Risks

Mumps can damage the testicles and impair fertility, but the leap from “mumps infection” to “permanent sterility” is larger than most people assume. The virus causes testicular inflammation, called orchitis, in a meaningful fraction of post-pubertal males who contract it, and that inflammation can lead to reduced sperm production and hormonal disruption. Whether those effects become permanent depends on several factors, including whether one or both testicles are affected and how the infection is managed.

How Often Mumps Actually Reaches the Testicles

Mumps is best known for the telltale swollen cheeks from inflamed salivary glands, but the virus doesn’t always stop there. In a large Korean study using national health insurance records, about 1.9% of all mumps patients experienced complications, and orchitis was the single most common complication in males, accounting for roughly 42% of mumps-related complications among men.¹ The risk is heavily concentrated in post-pubertal males. Prepubertal boys who catch mumps rarely develop orchitis, and when they do, it almost never affects future fertility. For teenagers and adult men, the picture is different.

Orchitis typically shows up about four to eight days after the parotid gland swelling begins, though it occasionally appears without any salivary gland involvement at all. Most cases are unilateral, meaning only one testicle is affected. Bilateral orchitis, where both testicles become inflamed, occurs in a smaller subset but carries substantially higher risk for lasting fertility problems.

What the Virus Does Inside the Testicle

The damage from mumps orchitis unfolds in stages. The infection triggers swelling and congestion within the testicle, along with an influx of immune cells into the tissue between the sperm-producing tubes. Because the testicle is encased in a tough, inelastic membrane called the tunica albuginea, the swelling has nowhere to go. The rising pressure squeezes the seminiferous tubules, the tiny tubes where sperm are made, and can cut off their blood supply. Sperm production stalls, and the dead cells, debris, and immune cells accumulate. In severe cases, the tubules scar over and shrink permanently.²

At a cellular level, the virus targets two critical types of testicular cells. Sertoli cells, which nurture developing sperm, are a primary site of infection. When the virus infects Sertoli cells, it triggers the production of an inflammatory molecule called TNF-α, which disrupts the blood-testis barrier. This barrier normally shields developing sperm from the immune system, so when it breaks down, the immune system can begin attacking sperm cells directly.³ Research in mice has shown that this barrier disruption and the resulting impairment of sperm production are transient in many cases, but the extent of recovery varies.

The Testosterone Problem

Sperm production gets most of the attention, but mumps also hits the cells responsible for making testosterone. Leydig cells, scattered between the seminiferous tubules, are the body’s primary testosterone factory, and the mumps virus infects them directly. Lab studies have shown that the virus can completely shut down testosterone secretion from infected Leydig cells.⁴

A more recent study using human testis tissue confirmed these findings in detail. Testosterone levels progressively dropped after infection, falling to about 17% of normal levels by day ten. The drop wasn’t because Leydig cells died off; their numbers stayed roughly the same. Instead, the virus specifically disrupted a key enzyme in the testosterone-production pathway, essentially leaving the machinery intact but jamming one critical gear.⁵ In clinical practice, testosterone levels often recover as the infection resolves, but men with severe bilateral orchitis may experience longer-lasting hormonal effects, including reduced sex drive and fatigue.

Anti-Sperm Antibodies and Lingering Semen Changes

Even after the acute infection clears, the damage can echo through the reproductive system in subtler ways. One case report documented prolonged virus shedding in semen after mumps orchitis, along with a temporary but significant drop in sperm count and severe abnormalities in sperm shape. The patient also developed anti-sperm antibodies, which are immune proteins that target the man’s own sperm.⁶ This makes biological sense given how the blood-testis barrier breaks down during infection, as described earlier. Once the immune system “sees” sperm, it can continue producing antibodies against them even after the barrier heals.

Anti-sperm antibodies can interfere with fertility by clumping sperm together, preventing them from reaching the egg, or blocking fertilization. Not every man who develops orchitis will produce these antibodies, but their presence adds another layer of risk beyond the direct physical damage to testicular tissue.

From Orchitis to Sterility: How Common Is Permanent Damage?

This is where the popular narrative overreaches. The fear that “mumps makes you sterile” has been passed down for generations, and while it isn’t baseless, it overstates the typical outcome. Most men who develop unilateral orchitis recover their fertility. The unaffected testicle continues producing sperm normally, and even the affected one often partially recovers over time. Testicular atrophy, the permanent shrinkage of the affected testicle, does occur in some cases, but atrophy of one testicle doesn’t necessarily equal infertility because the other can compensate.

Bilateral orchitis is the scenario that genuinely threatens sterility, and it occurs in a minority of orchitis cases. Even among men with bilateral involvement, complete sterility (producing no sperm at all) is less common than subfertility, a reduced but not absent ability to conceive. However, the research base on long-term outcomes is thinner than you might expect for a condition this well known. Large, controlled follow-up studies tracking semen quality years after mumps orchitis are scarce, which means that exact percentages for permanent infertility are not reliably established.

How Orchitis Is Diagnosed

The diagnosis is usually clinical: a post-pubertal male develops testicular pain and swelling in the context of mumps infection or recent exposure, and the picture is fairly clear. Ultrasound with color Doppler imaging is the most useful tool when the diagnosis is uncertain or when doctors need to rule out other causes like testicular torsion, which is a surgical emergency. In mumps orchitis, ultrasound typically shows an enlarged testicle with increased blood flow and thickening of the scrotal wall. One distinguishing feature compared to bacterial orchitis is the absence of significant fluid collection around the testicle.⁷ Color Doppler is more sensitive than standard ultrasound alone for picking up the inflammatory changes.⁸

Treatment Options During the Acute Phase

There is no antiviral drug approved specifically for mumps. Standard management of mumps orchitis is supportive: bed rest, scrotal elevation, ice packs, and pain control with anti-inflammatory drugs. The goal is to keep the patient comfortable while the immune system clears the virus. But a few small studies have explored more active interventions aimed at preventing the testicular atrophy that leads to infertility.

Interferon-alpha 2B, a synthetic version of a protein the immune system naturally produces to fight viruses, has shown encouraging results in case series. In one report, four patients with bilateral mumps orchitis received daily injections of interferon-alpha 2B for seven days. Symptoms resolved within two to four days, and over follow-up periods of six to fifteen months, none of the patients developed testicular atrophy.⁹ A separate case report described similarly rapid improvement with interferon-alpha 2a, with the infection resolving without lasting effects.¹⁰

These results are intriguing, but the evidence base is small. No large randomized trial has confirmed that interferon therapy prevents infertility after mumps orchitis, and the treatment isn’t part of standard guidelines in most countries. It remains more of a promising lead than an established standard of care. The lab finding that ribavirin can restore testosterone production in mumps-infected Leydig cells in vitro hasn’t translated into clinical practice either.

Assisted Reproduction When Fertility Is Lost

For men who do develop severe fertility impairment after mumps orchitis, modern reproductive medicine offers options that didn’t exist a generation ago. When a man produces no sperm in his ejaculate, a procedure called microdissection testicular sperm extraction (microTESE) can sometimes retrieve small numbers of sperm directly from testicular tissue. Those sperm are then used for in vitro fertilization with a technique called intracytoplasmic sperm injection, where a single sperm is injected directly into an egg.

A study comparing outcomes of this approach in mumps orchitis patients versus men with other causes of absent sperm found that the mumps group actually fared slightly better. The sperm retrieval rate for mumps orchitis patients was over 94%, and the fertilization rate was about 70%. The pregnancy rate after embryo transfer reached roughly 83%, and the ongoing pregnancy rate was 69%.¹¹ A separate study reported a live-birth rate of 25% per cycle for mumps orchitis patients undergoing this procedure, comparable to the rate seen in other causes of sperm absence.¹²

The takeaway is that even for men who end up with the worst-case outcome from mumps orchitis, biological fatherhood is not necessarily out of reach. The procedures are expensive and not guaranteed, but the success rates are reasonable and comparable to those seen in other causes of severely impaired sperm production.

Why Young Adults Are Still Getting Mumps

You might assume mumps is a problem of the past in countries with routine childhood vaccination. It largely is, but not entirely. The MMR vaccine is highly effective, yet immunity wanes over time. A modeling study estimated that vaccine-derived protection lasts an average of about 27 years, which means many adults vaccinated in childhood may have reduced immunity by their twenties and thirties. The study estimated that over half of adults aged 20 to 29 were susceptible to mumps by 2006, contributing to outbreaks that have continued to flare in college campuses and other settings where young adults gather.¹³

Vaccination still provides significant protection even when immunity has partially faded. Research shows that vaccinated individuals who do contract mumps tend to have milder illness, with lower rates of fever, less bilateral gland swelling, and fewer complications including orchitis.¹⁴ In some outbreak situations, a third dose of MMR vaccine is recommended for people in affected communities. The key point is that even partially waned immunity from childhood vaccination offers a buffer against the complications that drive the fertility concerns.

The Emotional Weight of the Diagnosis

The anxiety around mumps and sterility isn’t just medical. For men dealing with infertility from any cause, the psychological burden can be considerable. Research consistently shows that male infertility is linked to depression, anxiety, reduced self-esteem, and disruptions to how men see their own identity. Cultural expectations that tie masculinity to fatherhood make the experience more isolating, and many men report suppressing their emotions about it rather than seeking support.¹⁵

For men who have had mumps orchitis, the uncertainty itself is stressful. Semen analysis can take months after the acute infection to stabilize, and the not-knowing period between the infection and final fertility assessment can be its own source of distress. If you’ve had mumps orchitis and are concerned about your fertility, getting a semen analysis several months after recovery provides the clearest picture. A single low result shortly after the infection doesn’t necessarily predict the long-term outcome, since sperm counts can take three to six months to rebound.

When Mumps Orchitis Happens in One Testicle Versus Both

Unilateral orchitis, by far the more common scenario, carries a much more reassuring prognosis. The unaffected testicle produces enough sperm and testosterone for normal function, and even the damaged testicle often retains some residual function. Some degree of atrophy on the affected side is common, which may be visible on ultrasound or noticeable as a size difference, but it doesn’t translate to clinical infertility in most men.

Bilateral orchitis is the situation that genuinely threatens reproductive capacity, and it’s also the scenario where early, aggressive management may matter most. The small studies on interferon therapy were specifically focused on bilateral cases, presumably because those patients had the most to lose. If you develop orchitis in both testicles during a mumps infection, pushing for evaluation by a urologist rather than relying solely on supportive care at home is a reasonable step, even though the evidence for specific interventions remains limited.

One common misconception worth correcting: “undescended testicle” and “mumps-related atrophy” are frequently confused in casual conversation, but they are entirely different conditions with different causes and different implications. Mumps orchitis affects normally descended testicles that become inflamed during viral infection. The atrophy that follows, when it occurs, is an acquired change from inflammation, not a developmental anomaly.